ConductScience.org, home

Trial · NCT07907237

Feasibility Study on the Use of a Walking Exoskeleton in the Intensive Care Unit

NCT07907237, Not applicable, Not yet recruiting, CHU de Reims

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Feasibility Study on the Use of a Walking Exoskeleton in the Intensive Care Unit. Trials, record NCT07907237. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907237

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Feasibility Study on the Use of a Walking Exoskeleton in the Intensive Care Unit
NCT number
NCT07907237
Status
Not yet recruiting
Phases
Not applicable
Enrollment
30 participants, estimated
Lead sponsor
CHU de Reims
Conditions
Neuromuscular Disease in Post-Intensive Care Syndrome
Interventions
rehabilitation session assisted by an exoskeleton
First posted
2026-10-30
Last updated
2026-10-30

Source ClinicalTrials.gov

Registered outcomes23

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysEligibility rate, defined as the number of eligible participants relative to the number of patients in the ICU
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysEnrollment rate, defined as the number of participants enrolled in the study relative to the number of eligible patients
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysInitiation rate, defined as the number of included participants who complete at least one session
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysNumber of completed sessions
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysSetup and session duration
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysRate of completed sessions relative to the number of scheduled sessions
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysTechnical failure rate (malfunction, calibration difficulties, anatomical incompatibility)
PrimaryFeasibility of Exoskeleton-Assisted RehabilitationUp to 14 daysReasons for session termination
SecondaryPatient acceptabilityUp to 14 daysnumber of initial refusals
SecondaryPatient acceptabilityUp to 14 daysthe dropout rate

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07907237

GET https://conductscience.org/api/trials/v1/NCT07907237/registered?page=2